MedPath

Study Comparing Regional Anesthetic Blocks and Periarticular Infiltration for the Management of Post-operative Pain After Direct Anterior Total Hip Arthroplasty

Not Applicable
Terminated
Conditions
Degenerative Joint Disease
Registration Number
NCT02904993
Lead Sponsor
Mayo Clinic
Brief Summary

To compare two methods of post-operative pain management in patients undergoing total hip arthroplasty. There is a perception that the periarticular injections may not be as effective in controlling post-operative pain.

Both methods are current standard of care. The investigators want to compare the outcomes of each when patients are randomized to one of the methods compared to the other method of post-operative pain control.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
9
Inclusion Criteria
  • Subject scheduled for Direct Anterior unilateral total hip replacement
  • Weight ≥ 50 and ≤125 kg
  • Intact neurological exam
  • Cognitively intact with ability to sign consent
Exclusion Criteria
  • Renal insufficiency with creatinine > 1.5 mg/dl
  • Allergic to any of the following : Ropivacaine, Epinephrine, Ketorolac, Morphine sulfate, NSAIDs, Tylenol, Neurontin, Morphine, Oxycodone or Dilaudid.
  • Subject taking regular narcotic medications prior to surgery (20mg/day Morphine equivalents for >7days)
  • Subject with prior open hip surgery who received regional anesthesia or periarticular injection for post op pain management.
  • Subject with contraindication for spinal anesthesia

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Changes in pain scorepost-operative to 7 days

Static and dynamic post-operative pain scores, measured on a 1 - 10 visual analogue scale.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mayo Clinic in Florida

🇺🇸

Jacksonville, Florida, United States

Mayo Clinic in Florida
🇺🇸Jacksonville, Florida, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.